22nd Century Group
XXII
About: 22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
Employees: 56
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
160% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 5
67% more funds holding
Funds holding: 12 [Q1] → 20 (+8) [Q2]
6.17% more ownership
Funds ownership: 0.46% [Q1] → 6.63% (+6.17%) [Q2]
31% less capital invested
Capital invested by funds: $364K [Q1] → $250K (-$114K) [Q2]
Financial journalist opinion
Based on 5 articles about XXII published over the past 30 days